购物车 0 ￥ 0.00
微信关注
申请试用装

Cell Cycle

产品 201 到 250 共 257个

每页
页面：
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

设置降序顺序
  1. (-)-BAY-1251152
    Quick View

    (-)-BAY-1251152

    Catalog No. A21570
    Quick View
    PTEF/CDK9 inhibitor
    (-)-BAY-1251152 is an enanthiomer of BAY-1251152 with rotation (-). BAY-1251152 is a potent and highly selective PTEF/CDK9 inhibitor. 了解更多
  2. Lerociclib dihydrochloride
    Quick View

    Lerociclib dihydrochloride

    Catalog No. A21577
    Quick View
    CDK4/CDK6 inhibitor
    Lerociclib dihydrochloride (G1T38 dihydrochloride) is a potent and selective inhibitor of CDK4/CDK6, with IC50s of 1 nM and 2 nM for CDK4/CyclinD1 and CDK6/CyclinD3, respectively. 了解更多
  3. LDC4297
    Quick View

    LDC4297

    Catalog No. A21613
    Quick View
    CDK7 inhibitor
    LDC4297 is a potent and selective CDK7 inhibitor with an IC50 of 0.13 nM. 了解更多
  4. BS-181 hydrochloride
    Quick View

    BS-181 hydrochloride

    Catalog No. A21988
    Quick View
    CDK7 inhibitor
    BS-181 hydrochloride is a highly selective CDK7 inhibitor with IC50 of 21 nM, and > 40-fold selective for CDK7 than CDK1, 2, 4, 5, 6, or 9. 了解更多
  5. SEL120-34A HCl
    Quick View

    SEL120-34A HCl

    Catalog No. A21485
    Quick View
    CDK8 inhibitor
    SEL120-34A HCl is a potent, selective, orally available, ATP-competitive CDK8 inhibitor, with IC50s of 4.4 nM and 10.4 nM for CDK8/CycC and CDK19/CycC, respectively, with antitumor activity. 了解更多
  6. NU6300
    Quick View

    NU6300

    Catalog No. A21025
    Quick View
    ATP-competitive CDK2 inhibitor
    NU6300 is the first covalent ATP-competitive CDK2 inhibitor. 了解更多
  7. Roscovitine (Seliciclib)
    Quick View

    Roscovitine (Seliciclib)

    Catalog No. A10806
    Quick View
    CDK 抑制剂
    Roscovitine (Seliciclib)是一种CDK抑制剂，可优先抑制多种酶靶标，包括CDK2，CDK7和CDK9。 了解更多
  8. PHA-767491
    Quick View

    PHA-767491

    Catalog No. A11164
    Quick View
    Cdc7/cdk9 抑制剂
    PHA-767491是一种有效的，具有ATP竞争性的双重cdc7/cdk9抑制剂 (IC50值分别为10和34 nM)，可防止DNA复制的启动。 了解更多
  9. Kenpaullone
    Quick View

    Kenpaullone

    Catalog No. A11220
    Quick View
    CDK 抑制剂
    Kenpaullone是CDK1/细胞周期蛋白B（IC 50 = 400 nM），CDK2/细胞周期蛋白A（IC 50 = 680nM），CDK5（IC 50 = 850nM）的有效抑制剂，对其他激酶的作用要小得多。 了解更多
  10. BMS-863233 (XL-413)
    Quick View

    BMS-863233 (XL-413)

    Catalog No. A13677
    Quick View
    CDK 抑制剂
    BMS-863233，也称为XL-413，是一种具有潜在抗肿瘤活性的细胞分裂周期7同系物（CDC7）激酶抑制剂。 了解更多
  11. PD 0332991 Isethionate
    Quick View

    PD 0332991 Isethionate

    Catalog No. A13811
    Quick View
    CDK4/6 抑制剂
    PD 0332991 Isethionate是CDK4/6的高选择性抑制剂，IC50分别为11 nM/16 nM。 了解更多
  12. PHA-793887
    Quick View

    PHA-793887

    Catalog No. A10716
    Quick View
    CDK 抑制剂
    PHA-793887是一种新型有效的CDK2，CDK5和CDK7抑制剂，IC50分别为8 nM，5 nM 和10 nM，作用于CDK2，5，和7比作用于CDK1，4，和9选择性高6倍以上。可在低浓度下靶向多种细胞周期蛋白依赖性激酶，并具有针对多种癌细胞的高活性。 了解更多
  13. BAY 1000394 (Roniciclib)
    Quick View

    BAY 1000394 (Roniciclib)

    Catalog No. A12742
    CDK 抑制剂
    BAY 1000394 (Roniciclib)是一种口服生物利用细胞周期蛋白依赖性激酶（CDK）抑制剂，具有潜在的抗肿瘤活性。 了解更多
  14. Dinaciclib (SCH 727965)
    Quick View

    Dinaciclib (SCH 727965)

    Catalog No. A11129
    Quick View
    CDK 抑制剂
    Dinaciclib (SCH 727965)是一种有效且选择性的细胞周期蛋白依赖性激酶（CDK）抑制剂，选择性抑制CDK1，CDK2，CDK5和CDK9，IC50值分别为3、1、1和4 nM。 了解更多
  15. Flavopiridol (Alvocidib)
    Quick View

    Flavopiridol (Alvocidib)

    Catalog No. A10390
    Quick View
    CDK 抑制剂
    Flavopiridol（Alvocidib）是一种细胞周期蛋白依赖性激酶抑制剂，与ATP竞争性抑制CDK，包括CDK1， CDK2， CDK4和CDK6，CDK9。作用于CDK1， 2， 4， 6，9比作用于CDK7更具有选择性，用于治疗慢性淋巴细胞性白血病。 了解更多
  16. A-674563
    Quick View

    A-674563

    Catalog No. A11034
    Quick View
    Akt 抑制剂
    A-674563是一种B/Akt抑制剂，IC50为14 nM，并且还显示出对PKA和CDK2的抑制活性，IC50分别为16和46 nM。 了解更多
  17. PD 0332991 HCl (Palbociclib)
    Quick View

    PD 0332991 HCl (Palbociclib)

    Catalog No. A10701
    Quick View
    CDK 4/6 抑制剂
    PD 0332991 HCl (Palbociclib)是一种高度选择性的CDK4/6抑制剂，它对CDK1/2/5，EGFR，FGFR，PDGFR，InsR等没有抑制活性，具有潜在的抗肿瘤活性。 了解更多
  18. LY2835219 (abemaciclib)
    Quick View

    LY2835219 (abemaciclib)

    Catalog No. A12989
    Quick View
    CDK4/6 抑制剂
    LY2835219 (abemaciclib)是一种细胞周期蛋白依赖性激酶（CDK）抑制剂，靶向CDK4（cyclin D1）和CDK6（cyclin D3）细胞周期途径，具有潜在的抗肿瘤活性。 了解更多
  19. Palbociclib
    Quick View

    Palbociclib

    Catalog No. A14427
    Quick View
    CDK 抑制剂
    Palbociclib是一种吡啶并嘧啶衍生的细胞周期蛋白依赖性激酶（CDK）抑制剂，具有潜在的抗肿瘤活性。 了解更多
  20. AZD7762
    Quick View

    AZD7762

    Catalog No. A10113
    Quick View
    Chk1 & Chk2 抑制剂
    AZD7762是一种有效的ATP竞争性检查点激酶抑制剂，可促进检查点废止并增强DNA靶向疗法。 了解更多
  21. CHIR-124
    Quick View

    CHIR-124

    Catalog No. A11046
    Quick View
    CHK 抑制剂
    CHIR-124是一种新型有效的Chk1抑制剂（Chk1和Chk2的IC50：分别为0.32 nM和697 nM）。 了解更多
  22. CCT241533
    Quick View

    CCT241533

    Catalog No. A11108
    Quick View
    Chk2 抑制剂
    CCT241533是CHK2的有效和选择性抑制剂，可增强PARP抑制剂的细胞毒性。 了解更多
  23. PF 477736
    Quick View

    PF 477736

    Catalog No. A11520
    Quick View
    Chk 抑制剂
    PF 477736是选择性检查点激酶1 (Chk1)抑制剂(Chk1和Chk2的ki值分别为0.49和47 nM)。 了解更多
  24. SCH900776 (S-isomer)
    Quick View

    SCH900776 (S-isomer)

    Catalog No. A12703
    Quick View
    CHK1 抑制剂
    SCH900776 (S-isomer)是靶向细胞周期检查点激酶1（Chk1）抑制剂，无细胞试验中IC50为3 nM，比作用于Chk2选择性高500倍。具有潜在的放射增敏和化学增敏活性。 了解更多
  25. BML-277
    Quick View

    BML-277

    Catalog No. A13575
    Quick View
    Chk2 抑制剂
    BML-277（Chk2抑制剂II）是Chk2（检查点激酶2）抑制剂。 了解更多
  26. GNE-900
    Quick View

    GNE-900

    Catalog No. A14178
    Chk1 抑制剂
    GNE-900是一种ATP竞争性、选择性和生物可利用的chk1抑制剂。 了解更多
  27. LY2606368
    Quick View

    LY2606368

    Catalog No. A13684
    Quick View
    Chk1 抑制剂
    LY2606368是具有潜在抗肿瘤活性的检查点激酶1（chk1）抑制剂。 了解更多
  28. PD0166285
    Quick View

    PD0166285

    Catalog No. A15863
    Quick View
    Wee1 抑制剂
    PD0166285是一种有效的Wee1和Chk1抑制剂，在纳摩尔浓度下具有活性。PD0166285是一种新型的G2检查点消除剂。 了解更多
  29. GDC-0575 (ARRY-575, RG7741)
    Quick View

    GDC-0575 (ARRY-575, RG7741)

    Catalog No. A16811
    Quick View
    Chk1 抑制剂
    GDC-0575 (ARRY-575,RG7741)是一种有效的选择性CHK1抑制剂，IC50为1.2 nM。 了解更多
  30. CCT245737
    Quick View
    • 最新产品

    CCT245737

    Catalog No. A17239
    Quick View
    CHK1 inhibitor
    CCT245737 is a potent, selective and orally active checkpoint kinase 1 (CHK1) inhibitor. CCT245737 showed CHK1 IC50 = 1.3 nM, CHK2 IC50 = 2440 nM, G2 check point abrogation IC50 = 30 nM. Mouse F (oral)=100%. 了解更多
  31. CHK1-IN-3
    Quick View

    CHK1-IN-3

    Catalog No. A18443
    Quick View
    CHK1 inhibitor
    CHK1-IN-3 is a Checkpoint Kinase 1 (CHK1) inhibitor with an IC50 of 0.4 nM. 了解更多
  32. GSK461364
    Quick View

    GSK461364

    Catalog No. A10442
    Quick View
    PLK 抑制剂
    GSK461364 是polo样激酶1 (Plk1)的ATP竞争性抑制剂。 了解更多
  33. HMN-214
    Quick View

    HMN-214

    Catalog No. A10452
    Quick View
    PLK 抑制剂
    HMN-214抑制polo样和细胞周期蛋白依赖性激酶活性，具有强有力的抗微管作用，并在广泛的人类异种移植物中导致深度凋亡和抗肿瘤活性。 了解更多
  34. TAK-960
    Quick View

    TAK-960

    Catalog No. A11146
    Quick View
    PLK1 抑制剂?
    TAK-960是新型的，口服可用的polo样激酶1选择性抑制剂，具有广谱的临床前抗肿瘤活性。 了解更多
  35. ON-01910 (rigosertib)
    Quick View

    ON-01910 (rigosertib)

    Catalog No. A10673
    Quick View
    PLK 抑制剂
    ON-01910 (rigosertib)通过涉及PI3K/AKT抑制和氧化应激诱导的双重作用机制对慢性淋巴细胞白血病细胞具有选择性的细胞毒性。 了解更多
  36. MLN 0905
    Quick View

    MLN 0905

    Catalog No. A12429
    Quick View
    PLK1 抑制剂
    MLN0905是有效的选择性小分子PLK1抑制剂。MLN0905抑制包括DLBCL细胞系在内的多种人类肿瘤细胞的细胞增殖。 了解更多
  37. R1530
    Quick View

    R1530

    Catalog No. A13111
    Quick View
    Chk2, KDR, FGFR, Aurora A & Cdk2 抑制剂
    R1530是吡唑并苯并二氮杂小分子，具有潜在的抗血管生成和抗肿瘤活性。R1530也是一种有丝分裂-血管生成抑制剂(MAI),可抑制多种参与血管生成的受体酪氨酸激酶，如血管内皮生长因子受体(VEGFR)-1，-2，-3，血小板衍生生长因子受体(PDGFR)βFMS样酪氨酸激酶(Flt)-3和成纤维细胞生长因子受体(FGFR) -1，-2。 了解更多
  38. RO3280
    Quick View

    RO3280

    Catalog No. A13245
    Quick View
    PLK1 抑制剂
    RO3280是一种有效的，高选择性的Polo样激酶1（PLK1）抑制剂，IC50为3 nM。 了解更多
  39. NMS-1286937
    Quick View

    NMS-1286937

    Catalog No. A13045
    Quick View
    PLK 抑制剂
    NMS-1286937是一种小分子Polo样激酶1（PLK1）抑制剂，具有潜在的抗肿瘤活性。 了解更多
  40. SBE 13 HCl
    Quick View

    SBE 13 HCl

    Catalog No. A14426
    Quick View
    PLK 抑制剂
    SBE 13 HCl是PLK1的选择性抑制剂，对于PLK1，PLK3和PLK2，IC 50值分别为200pM，875nM和66μM。 了解更多
  41. CCT241533 hydrochloride
    Quick View

    CCT241533 hydrochloride

    Catalog No. A15038
    Quick View
    Chk2 抑制剂
    CCT241533 hydrochloride是一种有效的丝氨酸/苏氨酸检查点激酶（Chk2）抑制剂，IC50为3 nM；显示在1 uM下与一组激酶的交叉反应最小。 了解更多
  42. CCT244747
    Quick View

    CCT244747

    Catalog No. A15550
    Quick View
    CHK1 抑制剂
    CCT244747是一种新型的有效，高选择性活性，ATP竞争性CHK1抑制剂，具有潜在的抗癌活性， 了解更多
  43. SB 218078
    Quick View

    SB 218078

    Catalog No. A15480
    Quick View
    Chk1 抑制剂
    SB 218078是检查点激酶1（Chk1）的抑制剂，对其他蛋白激酶具有选择性（Chk1，cdc2和PKC的IC50值分别为15、250和1000 nM）。 了解更多
  44. AAPK-25
    Quick View

    AAPK-25

    Catalog No. A19085
    Quick View
    Aurora/PLK dual 抑制剂
    AAPK-25 is a potent and selective Aurora/PLK dual inhibitor with anti-tumor activity, which can cause mitotic delay and arrest cells in a prometaphase, reflecting by the biomarker histone H3Ser10 phosphorylation and followed by a surge in apoptosis. 了解更多
  45. Poloxime
    Quick View

    Poloxime

    Catalog No. A12145
    Quick View
    PLK1 inhibitor
    Poloxime, a hydrolysis product of poloxin, is a non-ATP-competitive Plk1 inhibitor, with moderate Plk1 inhibitory activity. 了解更多
  46. CHK1-IN-2
    Quick View

    CHK1-IN-2

    Catalog No. A13142
    Quick View
    CHK1 inhibitor
    CHK1-IN-2 is a checkpoint kinase 1 (CHK1) inhibitor, with an IC50 of 6 nM. 了解更多
  47. Poloxin
    Quick View

    Poloxin

    Catalog No. A11524
    Quick View
    PLK1 inhibitor
    Poloxin is a non-ATP competitive Polo-like Kinase 1 (PLK1) inhibitor that targets the polo-box domain, with an IC50 of appr 4.8 μM. 了解更多
  48. Centrinone-B
    Quick View

    Centrinone-B

    Catalog No. A20855
    Quick View
    PLK4 inhibitor
    Centrinone-B (LCR-323) is a potent and highly selective PLK4 inhibitor, with a Ki of 0.59 nM. 了解更多
  49. Centrinone
    Quick View

    Centrinone

    Catalog No. A20858
    Quick View
    PLK4 inhibitor
    Centrinone (LCR-263) is a selective and reversible inhibitor of polo-like kinase 4 (PLK4) with a Ki of 0.16 nM. 了解更多
  50. GDC-0575 dihydrochloride
    Quick View

    GDC-0575 dihydrochloride

    Catalog No. A21567
    Quick View
    CHK1 inhibitor
    GDC-0575 dihydrochloride (ARRY-575 dihydrochloride) is an orally bioavailable CHK1 inhibitor, with an IC50 of 1.2 nM, and has antitumor activity. 了解更多

产品 201 到 250 共 257个

每页
页面：
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

设置降序顺序
FILTER BY:

购物选项

分类
  1. Chk (38)
  2. CDK (97)
  3. Aurora Kinase (37)
  4. PLK (14)
  5. ROCK (33)
  6. c-Myc (5)
  7. Wee1 (2)
  8. Ras (38)
  9. DYRK (11)
  10. G-quadruplex (3)
  11. RAD51 (3)
作用机制
  1. Inhibitor (抑制剂) (250)
  2. Agonist (激动剂) (1)
  3. Antagonist (拮抗剂) (1)
  4. Activator (激活剂) (2)
  5. Degrader (降解剂) (1)
靶点
  1. A3 adenosine receptor (1)
  2. Abl (3)
  3. Aurora A (28)
  4. Aurora B (22)
  5. Aurora C (11)
  6. Bcr-Abl (1)
  7. CDK (3)
  8. CDK2 (1)
  9. CDK4 (2)
  10. Chk2 (1)
  11. CYP3A4 (1)
  12. FAK (1)
  13. FGFR1 (4)
  14. FGFR2 (1)
  15. FGFR3 (1)
  16. FLT3 (6)
  17. IGF1R (1)
  18. JAK2 (4)
  19. JAK3 (1)
  20. Lck (1)
  21. MEK1 (2)
  22. MEK2 (1)
  23. PDE3 (1)
  24. PDGFRβ (1)
  25. RET (1)
  26. Src (3)
  27. TrkA (2)
  28. VEGFR2 (FLK1) (2)
联系我们
ChinaChina

Adooq 中国 (南京百鑫德诺生物科技有限公司)

免费电话: 400-025-6535

企业QQ: 400-025-6535

www.adooq.cn

sales@adooq.cn

United StatesUnited States

Adooq Bioscience

Toll Free: (866) 930-6790

Fax: +1-323-606-8156

Email: sales@adooq.com

Not your Region? View all Distributors

溶液配制计算器

分子量计算器

稀释计算器

摩尔浓度计算器

ADOOQ 产品质量保证
Guaranteed product quality, 365 days Unconditional Return & Replacement

We promise all products to perform as described.

立即申请
Get Code
联系我们
查看FAQs

Adooq 公司

产品订购

技术资源

地址

© 2006-2019 AdooQ BioScience （南京百鑫德诺生物科技有限公司）. All Rights Reserved.
苏ICP备14027875号
Accept Payment
Rewards